The 20 Best Malignant Mixed Mullerian Tumor Doctors Near Me in Livingston, NJ

Thad Denehy is an Oncologist practicing medicine in West Orange, New Jersey. Dr. Denehy is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Hysterectomy, and Oophorectomy. Dr. Denehy is board certified in American Board Of Obstetrics And Gynecology. Dr. Denehy is currently accepting new patients.

Since 1999, Dr. Daniel Tobias has been a gynecologic oncologist at Atlantic Health System’s Women’s Cancer Center, diagnosing and treating conditions of the female reproductive system. He is dual board-certified in obstetrics and gynecology and gynecologic oncology, and he is part of Atlantic Medical Group with privileges at both Morristown and Overlook medical centers. He is currently the director of gynecologic oncology for Atlantic Health System.Dr. Tobias attended the University of Missouri-Kansas City School of Medicine for an integrated six-year combined bachelors of arts and medical degree program. He performed his residency at Albert Einstein College of Medicine’s Montefiore Medical Center and his fellowship in gynecologic oncology at Mount Sinai School of Medicine in New York. During his fellowship, Dr. Tobias served as principal investigator of a study initiated by the New York Gynecologic Oncology Group. Keenly interested in research, Dr. Tobias continues to bring clinical trials and research to his patients.As part of an integrated care team, Dr. Tobias treats gynecologic malignancies using a combination of modalities and advanced technologies to spare healthy tissue. His medical career includes many honors, awards, presentations and authored works.Dr. Tobias is affiliated with and involved in several professional societies including the Society of Gynecology Oncologists and the American College of Obstetricians and Gynecologists. He has extensive experience with radical surgery, intraperitoneal chemotherapy and laparoscopic surgery. Dr. Tobias has performed robotic surgery since 2005, helped develop a comprehensive gynecologic oncology robotics program, and trains other physicians to perform robotics surgery. He also participates in resident education. Dr. Tobias is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tobias is board certified in American Board Of Obstetrics And Gynecology. Dr. Tobias is currently accepting new patients.

Nana Tchabo, MD, FACOG Dr. Nana Tchabo is dual board certified in gynecology-oncology and obstetrics and gynecology, with fellowship training in minimally invasive gynecologic surgery and robotic procedures. A native of Baltimore, MD, Dr. Tchabo is a gynecologic oncologist at Atlantic Health System’s Morristown and Overlook Medical Centers Women’s Cancer Center, part of the Atlantic Medical Group. After graduating from Brown University in 1996 with a bachelor’s degree in neuroscience and a minor in women’s health, Dr. Tchabo attended Brown University School of Medicine for her medical degree, where she was cited for academic excellence. Dr. Tchabo completed her residency in obstetrics and gynecology at Georgetown University in 2004 and pursued additional research training at the National Cancer Institute of the National Institutes of Health in Bethesda, MD, and gynecologic oncology fellowship training at Roswell Park Cancer Institute in Buffalo, NY. Committed to cancer prevention and survivorship, Dr. Tchabo is a principal investigator on many of the gynecologic cancer clinical research trials available at the Carol G. Simon Cancer Center. She also serves as associate residency director for Gynecology at Overlook Medical Center. Dr. Tchabo is an assistant clinical professor at the Sidney Kimmel Medical College of Thomas Jefferson University and is a former assistant clinical professor at Mount Sinai School of Medicine’s department of Obstetrics, Gynecology and Reproductive Science. Dr. Tchabo is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tchabo is board certified in American Board Of Obstetrics And Gynecology. Dr. Tchabo is currently accepting new patients.

Jason Knight is a Gynecologic Oncologist and an Oncologist practicing medicine in Morristown, New Jersey. Dr. Knight is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Oophorectomy, and Hysterectomy. Dr. Knight is currently accepting new patients.

Jennifer Wagmiller is an Oncologist practicing medicine in Livingston, New Jersey. Dr. Wagmiller is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Breast Cancer, and Paget Disease of the Breast. Dr. Wagmiller is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS). Dr. Huannou is board certified in American Board Of Internal Medicine. Dr. Huannou is currently accepting new patients.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration. Dr. Strauss is board certified in American Board Of Internal Medicine. Dr. Strauss is currently accepting new patients.

Karleung Siu is a Hematologist and an Oncologist practicing medicine in Florham Park, New Jersey. Dr. Siu is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Siu is board certified in American Board Of Internal Medicine. Dr. Siu is currently accepting new patients.

Indu Sabnani is a Hematologist and an Oncologist practicing medicine in Maplewood, New Jersey. Dr. Sabnani is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, Pancreatic Cancer, and Bone Marrow Aspiration. Dr. Sabnani is board certified in American Board Of Internal Medicine. Dr. Sabnani is currently accepting new patients.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration. Dr. Scola is board certified in American Board Of Internal Medicine. Dr. Scola is currently accepting new patients.

Shannon Tomita, MD, is a fellowship-trained gynecologic oncologist with Atlantic Women’s Cancer Associates, specializing in cancers of the female reproductive system. She has comprehensive clinical experience with women of all ages and applies her knowledge and skills to detect, treat, and cure cancer in her patients. With an interest in advancing women’s health, Dr. Tomita is privileged to care for women with cancer and compassionate in her approach. She is proficient in minimally invasive procedures such as gynecologic robotic and laparoscopic surgery and was the recipient of the Resident’s Achievement Award for excellence in laparoscopic surgery by the Society of Laparoendoscopic Surgeons. Out of the operating room, she is also skilled at administering chemotherapy as well as targeted and novel therapeutics in the treatment of gynecologic malignancies. In addition to her expertise in managing complex gynecologic cancers Dr. Tomita has collaborated on research into the early detection of gynecologic cancer, understanding the genetics of ovarian cancer, and the treatment of endometrial, ovarian, and other cancers of the female reproductive system. She is a member of the Society of Gynecological Oncology. After earning her degree from the State University of New York Downstate, Dr. Tomita completed her residency at Mount Sinai West/Mount Sinai St. Luke’s, in NYC. Following this, she spent two years in the Mount Sinai Ovarian Cancer Translational Research Lab in the Department of Genetics and Genomic Sciences, after which she pursued fellowship training at the Icahn School of Medicine at Mount Sinai, a program at the forefront of providing the highest level of care and robust training in gynecologic oncology. Dr. Tomita is a participating provider of the Atlantic Accountable Care Organization. Dr. Tomita is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Endometrial Cancer, Oophorectomy, and Hysterectomy. Dr. Tomita is board certified in American Board Of Obstetrics And Gynecology. Dr. Tomita is currently accepting new patients.

Raquel Wagman is a Radiation Oncologist practicing medicine in Livingston, New Jersey. Dr. Wagman is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Intraductal Papilloma, Vulvar Cancer, Cervical Cancer, and Neuroendocrine Carcinoma of the Cervix.

Dr. Saksena is a dynamic, clinically oriented, hematologist/oncologist with several years of experience in the treatment of various cancers and blood disorders. She is triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Her strong medical back- ground combined with her passion to build meaningful patient-centered relationships enables her to deliver leading-edge care in a highly personalized manner. She practices comprehensive cancer care, with direct access to the latest clinical trials, and works closely with surgeons, radiation oncologists, genetic counselors, nurses, social workers and dietitians.Dr. Saksena attended Lehigh University, where she obtained a bachelor of science degree in behavioral neuroscience. She earned her medical degree at Jefferson Medical College, part of Thomas Jefferson University in Philadelphia, and then completed her hematology/oncology fellowship at Rutgers Cancer Institute of New Jersey (CINJ) & Robert Wood Johnson University Hospital in New Brunswick.During her education, Dr. Saksena received a number of honors, awards and scholarships for her clinical work, leadership roles, and research. She served as chief fellow of hematology oncology while at Rutgers CINJ, the state’s only National Cancer Institue-designated cancer center. Dr. Saksena also speaks Hindi, Gujarati and conversational Spanish, and is committed to community outreach through advocacy groups and as a liaison of the American Medical Women’s Association.Dr. Saksena is a member of Atlantic Medical Group, and is a participating provider in the Atlantic Accountable Care Organization. Dr. Saksena is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Primitive Neuroectodermal Tumor (PNET).

Dr. Markowski has been contributing to the field of oncology since working in a cancer research lab during and after his undergraduate work at Johns Hopkins University. A desire to care for patients brought him back to his home state of New Jersey where he completed his medical school degree at Rutgers-Robert Wood Johnson Hospital in New Brunswick, NJ. He then completed internal medicine residency and subsequent hematology/oncology fellowship training at Rutgers-Robert Wood Johnson Hospital/Cancer Institute of New Jersey.Throughout his hematology and oncology career Dr Markowski has published and presented many peer-reviewed articles, abstracts, and posters on a multitude of cancer types. He has particular interest and expertise in lung cancer, gastrointestinal cancers, and breast cancer. In addition, he has extensive experience taking care of patients with both benign and malignant blood disorders. Dr. Markowski is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Markowski is board certified in American Board Of Internal Medicine. Dr. Markowski is currently accepting new patients.

Usman Shah is a Hematologist and an Oncologist practicing medicine in Summit, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Scott Richard is an Oncologist practicing medicine in Florham Park, New Jersey. Dr. Richard is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Cervical Cancer, Endometrial Stromal Sarcoma, Hysterectomy, and Oophorectomy.

Patrick Anderson is an Oncologist practicing medicine in Newark, New Jersey. Dr. Anderson is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Endometrial Cancer, Oophorectomy, and Salpingo-Oophorectomy.

Sarada Gurubhagavatula is a Hematologist and an Oncologist practicing medicine in Morristown, New Jersey. Dr. Gurubhagavatula is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Familial Pancreatic Cancer. Dr. Gurubhagavatula is board certified in American Board Of Internal Medicine. Dr. Gurubhagavatula is currently accepting new patients.

David Gallinson is a Hematologist and an Oncologist practicing medicine in Morristown, New Jersey. Dr. Gallinson is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Anemia, Paget Disease of the Breast, Breast Cancer, and Bone Marrow Aspiration. Dr. Gallinson is board certified in American Board Of Internal Medicine. Dr. Gallinson is currently accepting new patients.